SAF, If there is not a big difference at 195, e
Post# of 148288
If there is not a big difference at 195, either:
1. The result is not significant due to N=195 and we continue to 390.
2. As clams and AF claim, the drug is completely worthless and we all go home.
The first outcome is possible and we continue to 390. I am prepared for that, but do not believe it likely. The second outcome is possible only in a few small and deluded minds.
As we have seen, the evidence of MOA, CD10 and EINDs has built a strong, soon to be bullet proof, demonstration of just how remarkable leronlimab is in the reversal of immune dysregulation.
Clams et al, just remember that this immuno-modulation is not Covid 19 specific.
There is not one, but a fleet of steamrollers approaching. Act accordingly.